Project Details
| Status | Not started |
|---|
Keywords
- phase 1 study
- treatment safety
- treatment efficacy
- lymphoma
A Phase 1 Open-label, Multicenter Study Evaluating the Safety and Pharmacokinetics of Escalating Doses of IGM-2323 in Subjects with Relapsed/Refractory Non-Hodgkin Lymphomas
- Gregory, Gareth (Primary Chief Investigator (PCI))
Project: Research